Precision BioSciences, Inc.
DTIL
$4.71
$0.020.43%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 68.70M | 75.10M | 87.64M | 57.53M | 48.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.70M | 75.10M | 87.64M | 57.53M | 48.73M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 68.70M | 75.10M | 87.64M | 57.53M | 48.73M |
| SG&A Expenses | 35.30M | 34.19M | 35.05M | 36.42M | 39.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.86M | 91.30M | 94.93M | 92.10M | 92.46M |
| Operating Income | -26.16M | -16.21M | -7.29M | -34.57M | -43.74M |
| Income Before Tax | 7.17M | 11.48M | 15.79M | -19.99M | -42.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.17 | 11.48 | 15.79 | -19.99 | -42.53 |
| Earnings from Discontinued Operations | -- | -2.86M | 1.18M | -7.68M | -18.79M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.17M | 8.62M | 16.97M | -27.67M | -61.32M |
| EBIT | -26.16M | -16.21M | -7.29M | -34.57M | -43.74M |
| EBITDA | -22.76M | -11.98M | -2.16M | -28.56M | -36.92M |
| EPS Basic | 1.93 | 0.08 | 0.23 | -7.60 | -16.05 |
| Normalized Basic EPS | 1.25 | 0.27 | -0.29 | -3.75 | -7.04 |
| EPS Diluted | 1.89 | 0.05 | 0.20 | -7.60 | -16.05 |
| Normalized Diluted EPS | 1.23 | 0.26 | -0.31 | -3.76 | -7.04 |
| Average Basic Shares Outstanding | 27.31M | 23.16M | 19.71M | 16.54M | 15.19M |
| Average Diluted Shares Outstanding | 27.36M | 23.20M | 19.76M | 16.55M | 15.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
